LGND icon

Ligand Pharmaceuticals
LGND

Overview Fund Activity

255 hedge funds and large institutions have $1.95B invested in Ligand Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 106 increasing their positions, 61 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
255
Holders Change
+16
Holders Change %
+6.69%
% of All Funds
3.39%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
42
Increased
106
Reduced
61
Closed
22
Calls
$3.56M
Puts
$567K
Net Calls
+$2.99M
Net Calls Change
-$1.99M

Top Buyers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$29.7M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$12.3M
3
Franklin Resources
Franklin Resources
California
+$9.72M
4
DCM
Driehaus Capital Management
Illinois
+$7.18M
5
Fisher Asset Management
Fisher Asset Management
Washington
+$4.4M

Top Sellers

1
William Blair Investment Management
William Blair Investment Management
Illinois
-$20.6M
2
SDJVC
St. Denis J. Villere & Co
Louisiana
-$20.1M
3
FMI
F/M Investments
District of Columbia
-$8.72M
4
Aberdeen Group
Aberdeen Group
United Kingdom
-$7.77M
5
BlackRock
BlackRock
New York
-$5.74M
Name Holding Trade Value Shares
Change 		Shares
Change %
CFS
276
CGC Financial Services
Oregon
– -$300 -3 Closed
MFG
277
Mendota Financial Group
Wisconsin
– -$101 -1 Closed
8 9 10 11
12